特布他林半硫酸盐结构式
|
常用名 | 特布他林半硫酸盐 | 英文名 | Terbutaline sulfate |
---|---|---|---|---|
CAS号 | 23031-32-5 | 分子量 | 274.32 | |
密度 | 1.1840 (rough estimate) | 沸点 | 419.2ºC at 760 mmHg | |
分子式 | C12H19NO3.1/2H2O4S | 熔点 | 246-248ºC | |
MSDS | 中文版 美版 | 闪点 | 165.3ºC | |
符号 |
GHS08 |
信号词 | Warning |
特布他林半硫酸盐用途Terbutaline硫酸盐是肾上腺素能受体_beta_2激动剂。 |
中文名 | 硫酸叔丁宁按 |
---|---|
英文名 | 5-[2-(tert-butylamino)-1-hydroxyethyl]benzene-1,3-diol,sulfuric acid |
中文别名 | 特布他林半硫酸盐 | 硫酸特布他林 |
英文别名 | 更多 |
描述 | Terbutaline硫酸盐是肾上腺素能受体_beta_2激动剂。 |
---|---|
相关类别 | |
参考文献 |
[2]. Terbutaline |
密度 | 1.1840 (rough estimate) |
---|---|
沸点 | 419.2ºC at 760 mmHg |
熔点 | 246-248ºC |
分子式 | C12H19NO3.1/2H2O4S |
分子量 | 274.32 |
闪点 | 165.3ºC |
PSA | 228.42000 |
LogP | 4.24840 |
外观性状 | 结晶粉末 |
蒸汽压 | 8.92E-08mmHg at 25°C |
折射率 | 1.6900 (estimate) |
储存条件 | 放入紧密的贮藏器内,储存在阴凉,干燥的地方 |
稳定性 | 如果遵照规格使用和储存则不会分解 避免接触氧化物 |
水溶解性 | H2O: soluble100mg/mL, clear to slightly hazy, colorless to yellow |
分子结构 | 1、疏水参数计算参考值(XlogP): 2、氢键供体数量:10 3、氢键受体数量:15 4、可旋转化学键数量:8 5、互变异构体数量:15 6、拓扑分子极性表面积(TPSA):220 7、重原子数量:37 8、表面电荷:0 9、复杂度:286 10、同位素原子数量:0 11、确定原子立构中心数量:0 12、不确定原子立构中心数量:2 13、确定化学键立构中心数量:0 14、不确定化学键立构中心数量:0 15、共价键单元数量:3 |
计算化学 | |
更多 | 1.性状:未确定 2.密度(g/mL,25/4℃):未确定 3.相对蒸汽密度(g/mL,空气=1):未确定 4.熔点(ºC):246-248 5.沸点(ºC,常压):未确定 6.沸点(ºC,5.2kPa):未确定 7.折射率:未确定 8.闪点(ºC):未确定 9.比旋光度(º):未确定 10.自燃点或引燃温度(ºC):未确定 11.蒸气压(kPa,25ºC):未确定 12.饱和蒸气压(kPa,60ºC):未确定 13.燃烧热(KJ/mol):未确定 14.临界温度(ºC):未确定 15.临界压力(KPa):未确定 16.油水(辛醇/水)分配系数的对数值:未确定 17.爆炸上限(%,V/V):未确定 18.爆炸下限(%,V/V):未确定 19.溶解性:未确定 |
符号 |
GHS08 |
---|---|
信号词 | Warning |
危害声明 | H361 |
警示性声明 | P281 |
个人防护装备 | Eyeshields;Faceshields;full-face particle respirator type N100 (US);Gloves;respirator cartridge type N100 (US);type P1 (EN143) respirator filter;type P3 (EN 143) respirator cartridges |
危害码 (欧洲) | Xn:Harmful; |
风险声明 (欧洲) | R42/43;R63 |
安全声明 (欧洲) | S26-S36 |
危险品运输编码 | NONH for all modes of transport |
WGK德国 | 3 |
RTECS号 | DN9000000 |
Maternal Stress Combined with Terbutaline Leads to Comorbid Autistic-Like Behavior and Epilepsy in a Rat Model.
J. Neurosci. 35 , 15894-902, (2015) Human autism is comorbid with epilepsy, yet, little is known about the causes or risk factors leading to this combined neurological syndrome. Although genetic predisposition can play a substantial rol... |
|
The role of Cl- in the regulation of ion and liquid transport in the intact alveolus during β-adrenergic stimulation.
Exp. Physiol. 98(2) , 576-84, (2013) The epithelium of the developing lung displays an evolving liquid transport phenotype, in which Cl(-) secretion during fetal life is rapidly switched to Na(+) absorption perinatally. However, the mech... |
|
Inhaled Pharmacotherapy and Stroke Risk in Patients with Chronic Obstructive Pulmonary Disease: A Nationwide Population Based Study Using Two-Stage Approach.
PLoS ONE 10 , e0130102, (2015) Patients with chronic obstructive pulmonary disease (COPD) are at higher risk of stroke than those without COPD. This study aims to explore the impact of inhaled pharmacotherapy on stroke risk in COPD... |
BRICANYL |
Terbutaline hemisulfate salt |
(±)-a-[(tert-Butylamino)methyl]-3,5-dihydroxybenzyl alcohol sulfate (2:1) (salt) |
5-[2-(tert-Butylamino)-1-hydroxyethyl]benzol-1,3-diolsulfat(2:1)(salt) |
Terbutaline sulfate |
2-t-Butylamino-1-(3,5-dihydroxyphenyl)ethanol Terbutaline hemisulfate salt |
1-(3,5-dihydroxyphenyl)-2-(t-butylamino)ethanol sulfate |
MFCD00079584 |
Terbutaline hemisulfate |
(+/-)-terbutaline hemisulphate |
Brethine |
terbutaline sulphate |
Brethine (TN) |
rac-terbutaline sulfate |
5-{1-Hydroxy-2-[(2-methyl-2-propanyl)amino]ethyl}-1,3-benzenediol sulfate (2:1) |
2-t-Butylamino-1-(3,5-dihydroxyphenyl)ethanol |
5-[2-(tert-butylamino)-1-hydroxyethyl]benzene-1,3-diol sulfate (2:1) (salt) |
1,3-Benzenediol, 5-[2-[(1,1-dimethylethyl)amino]-1-hydroxyethyl]-, sulfate (2:1) (salt) |
2-t-Butylamino-1-(3,5-dihydroxyphenyl)ethanol,Terbutaline hemisulfate salt |
促C 17295000 Terbutalin su |
EINECS 245-386-3 |
BRETHAIRE |
5-[2-(tert-Butylamino)-1-hydroxyethyl]benzene-1,3-diol sulfate (2:1) |
5-[2-[(1,1-Dimethylethyl)amino]-1-hydroxyethyl]-1,3-benzenediol sulfate (2:1) (salt) |
5-{2-[(1,1-diméthyléthyl)amino]-1-hydroxyéthyl}benzène-1,3-diol sulfate (2:1) (salt) |
Terbutaline (sulfate) |